Balyasny Asset Management’s Marker Therapeutics MRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-7,319
Closed -$580K 1275
2019
Q2
$580K Buy
+7,319
New +$580K ﹤0.01% 1059